Business · 1 sources covering this

Biotech's recovery isn't a 'head fake.' These 3 stocks could lead the next leg up

Biotech remains one of the market's more out-of-favor sectors despite improving industry fundamentals. Here are three stocks trading near multiyear lows.

Share:X WhatsApp Reddit Facebook LinkedIn Open ↗

Coverage spectrum

0 L · 0 C · 1 R

How 1 sources are covering this

CNBCLean R·2h ago
Biotech's recovery isn't a 'head fake.' These 3 stocks could lead the next leg up
Biotech remains one of the market's more out-of-favor sectors despite improving industry fundamentals. Here are three stocks trading near multiyear lows.
Read at CNBC →

Embed this bias spectrum on your site

Paste this iframe wherever you'd like the widget to appear. Resizes responsively; no JS required.

<iframe
  src="https://statesidedaily.com/embed/cluster/ef5ec2a9ad40b845a64cb88e847b5c402f927dff"
  width="100%" height="320"
  style="border:0;max-width:680px"
  loading="lazy"
  title="Biotech's recovery isn't a 'head fake.' These 3 stocks could lead the next leg up"></iframe>

Biotech's recovery isn't a 'head fake.' These 3 stocks could lead the next leg up

How 1 sources are covering this

Biotech's recovery isn't a 'head fake.' These 3 stocks could lead the next leg up

More from Business

Big Banks Smash Earnings Records, but ‘Tectonic’ Risks Loom

Warsh Reiterates Fed’s Pledge to Get Inflation Down but Doesn’t Specify How

Bank earnings takeaways: From Goldman Sach's SpaceX IPO fees to JPMorgan's AI job cuts

Oil prices off highs after Trump abandons 20% protection fee on Strait of Hormuz traffic

Reader

Trust & legal

Across the network